<DOC>
	<DOC>NCT00688831</DOC>
	<brief_summary>The purpose is to study the safety of AZD1305, how AZD1305 is tolerated and how the medication is metabolised by the body (how it is taken up into the body, distributed around the body and disappears from the body</brief_summary>
	<brief_title>Single Ascending Dose Study (SAD) iv Formulation</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Healthy volunteers BIM 1930 kg/m2 Potassium outside normal reference values ECG findings outside normal range</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>AZD1305</keyword>
	<keyword>SAD</keyword>
	<keyword>safety</keyword>
	<keyword>pharmcokinetics</keyword>
	<keyword>Safety and tolerability</keyword>
</DOC>